| Patent Number |
Title Of Patent |
Date Issued |
| 5416242 |
Hydroquinone derivative |
May 16, 1995 |
| Novel hydroquinone derivatives of the formulae (I) and (II), ##STR1## wherein R.sup.1 is an alkyl group having 7 to 11 carbon atoms, ##STR2## wherein each of R.sup.2 to R.sup.5 is independently a hydrogen atom, a lower alkyl group or a lower alkoxy group provided that at least on |
| 5276058 |
3,4-dihydroxychalcone derivatives |
January 4, 1994 |
| Novel 3,4-dihydroxychalcone derivatives useful as a pharmaceutical material, and novel anti-inflammatory preparations. The 3,4-dihydroxychalcone derivatives are compounds of the formula [I], ##STR1## wherein X is a substituted phenyl group represented, e.g., by the formula (i), |
| 5264421 |
Food composition |
November 23, 1993 |
| A food composition prepared from a lactic acid fermented aqueous liquorice extract which is free of the disadvantages of extremely strong sweetness which makes liquorice extracts unsuitable for maintaining and enhancing the pharmacological activities (both disease preventing and treating |
| 5194445 |
Ascorbic acid derivative |
March 16, 1993 |
| The preparation for preventing and curing organ dysfunctions, provided by the present invention, is a medicament having the activity to prevent and cure organ dysfunctions which active oxygen species and active organic radical species would cause, and unconventionally improved in stabili |
| 5143648 |
Ascorbic acid derivative and use as antioxidant |
September 1, 1992 |
| This invention relates to a novel ascorbic acid derivative having excellent antioxidant action and a process for preparing the same.Furthermore, this invention also relates to a novel antioxidant comprising the aforementioned ascorbic acid derivative or other known ascorbic acid derivati |
| 5141547 |
Process for production of molded glass article |
August 25, 1992 |
| A process for the production of a molded glass article is disclosed, said process comprises the steps of: applying wet treatment to a surface of a lead oxide-containing glass material, thereby forming a hydrated layer having a lower lead oxide content than that of a basic glass; heating |
| 5109025 |
Therapeutic agent for penal disorders |
April 28, 1992 |
| 2',3,4,4'-tetrahydroxychalcone and pharmacologically acceptable salts thereof are used as a therapeutic agent for treatment of renal disorders, and have activity for treatment of renal disorders and also for treatment of renal disorders accompanied by digestive disorders, and/or general |
| 5061812 |
Ascorbic acid derivative |
October 29, 1991 |
| This invention relates to a novel ascorbic acid derivative having excellent antioxidant action and a process for preparing the same.Furthermore, this invention also relates to a novel antioxidant comprising the aforementioned ascorbic acid derivative or other known ascorbic acid derivati |
| 5053490 |
Useful substance-albumin complex |
October 1, 1991 |
| A powdery complex is obtained by combining a useful substance such as vitamin E and liquid fatty oil with albumin. This powdery complex has excellent storage stability and can keep the useful substance contained therein stably for a long time. |
| 5051406 |
Pharmaceutical composition using albumin as a carrier and process for producing the same |
September 24, 1991 |
| The pharmaceutical composition of the present invention is a pharmaceutical composition of high drug content containing 1-200 parts by weight of a drug having a protein binding property and 100 parts by weight of albumin.This pharmaceutical composition is produced by stirring the drug and |
| 5034543 |
Ascorbic acid derivative and use as antioxidants |
July 23, 1991 |
| This invention relates to a novel ascorbic acid derivative having excellent antioxidant action, particularly eliminating action on superoxides and a process for preparing the same. Furthermore, this invention also relates to a novel antioxidant comprising the afore-mentioned novel ascorb |
| 5004742 |
Benzothiazine-1,1-dioxide derivatives |
April 2, 1991 |
| The present invention relates to novel benzothiazine-1,1-dioxide derivatives. These benzothiazine-1,1-dioxide derivatives have a high hyaluronidase-inhibiting activity and accordingly can be used in drugs such as anti-inflammatory agent, anti-allergic agent and the like. |
| 4952564 |
Antiallergic agent |
August 28, 1990 |
| The present invention which is an antiallergic agent characterized by containing isoliquiritigenin as an effective component provides a novel antiallergic agent exhibiting a low toxicity and excellent antiallergic properties. |
| 4898890 |
Medicines for use in the therapy and prevention of kidney and liver diseases |
February 6, 1990 |
| A novel medicine containing isoliquiritigenin as the active ingredient is disclosed, which exhibits excellent effects when used as a medicine for the therapy and prevention of kidney diseases, a medicine for the therapy and prevention of liver diseases, and a medicine for the therapy and |
